A study of warning letters issued to clinical investigators and institutional review boards by the United States Food and Drug Administration.

Indian journal of medical ethics

Volumn 8, Issue 4, 2011, Pages 211-214

  Gogtay, N J ^a   Doshi, B M ^b   Kannan, S ^b   Thatte, U ^b  

^a KEM HOSPITAL   (India)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL TRIAL (TOPIC); DEVELOPING COUNTRY; DEVICE APPROVAL; DRUG APPROVAL; ETHICS; FOOD AND DRUG ADMINISTRATION; HUMAN; PRACTICE GUIDELINE; PROFESSIONAL STANDARD; STANDARD; TOTAL QUALITY MANAGEMENT; UNITED STATES;

CLINICAL TRIALS AS TOPIC; DEVELOPING COUNTRIES; DEVICE APPROVAL; DRUG APPROVAL; ETHICS COMMITTEES, RESEARCH; GUIDELINE ADHERENCE; HUMANS; QUALITY IMPROVEMENT; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 84855181778     PISSN: 09748466     EISSN: None     Source Type: Journal    
DOI: 10.20529/ijme.2011.082     Document Type: Article

References (0)